BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8908122)

  • 1. Comparison between allogeneic and xenogeneic lymphocyte reactivity.
    Palomera S; Baron C; Weil B; Lang P
    Transplant Proc; 1996 Oct; 28(5):2915-6. PubMed ID: 8908122
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of in vivo lymphocyte proliferation between allogeneic and xenogeneic heart transplantation in mice.
    Kellersmann R; Kellersmann A; Thiede A; Ulrichs K
    Microsurgery; 2003; 23(5):498-502. PubMed ID: 14558010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat endothelial cells induce selective proliferation of CD8-positive xenogeneic lymphocytes.
    Baron C; Palomera S; Bierre V; Vogt B; Chopin D; Lang P
    Transplant Proc; 1995 Aug; 27(4):2482-3. PubMed ID: 7652896
    [No Abstract]   [Full Text] [Related]  

  • 4. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mice.
    Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
    Transplant Proc; 1994 Dec; 26(6):3461-2. PubMed ID: 7998223
    [No Abstract]   [Full Text] [Related]  

  • 7. Xenoreactive T-cell lines initiate pancreatic islet graft destruction in vivo.
    Wolf L; Gill RG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):440-1. PubMed ID: 8438369
    [No Abstract]   [Full Text] [Related]  

  • 8. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B- and T-cell mediated xenogeneic transplant rejection by interleukin 12.
    Hosiawa KA; Wang H; DeVries ME; Garcia B; Jiang J; Zhou D; Cameron MJ; Zhong R; Kelvin DJ
    Transplantation; 2006 Jan; 81(2):265-72. PubMed ID: 16436971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new DNA synthesis inhibitors with potent immunosuppressive activity prolong allograft and xenograft survival in small and large animals.
    Goodman ER; Fiedor PS; Fein S; Sung RS; Athan E; Hardy MA
    Transplant Proc; 1996 Apr; 28(2):920-1. PubMed ID: 8623463
    [No Abstract]   [Full Text] [Related]  

  • 12. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondepleting anti-CD4 but not anti-CD8 antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1, 3-galactosyl-transferase knock-out mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams J; Byrne G; Diamond L; Logan J
    Transplant Proc; 2000 Aug; 32(5):1005. PubMed ID: 10936321
    [No Abstract]   [Full Text] [Related]  

  • 15. MLR and skin graft studies in xenogeneic iso-, allo-, and xeno-combinations using HLA-DP and -DQ transgenic mice.
    Hagihara M; Shimura T; Tsuchida F; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Apr; 26(2):967-8. PubMed ID: 8171718
    [No Abstract]   [Full Text] [Related]  

  • 16. Pig MHC mediates positive selection of mouse CD4+ T cells with a mouse MHC-restricted TCR in pig thymus grafts.
    Zhao Y; Swenson K; Sergio JJ; Sykes M
    J Immunol; 1998 Aug; 161(3):1320-6. PubMed ID: 9686594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic and xenogeneic cross-reactions in hyperimmune recipients.
    Di Stefano R; Carobbi A; Frosini F; Scavuzzo M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):446. PubMed ID: 8438372
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro comparison of human xenogeneic and allogeneic proliferative cellular immune responses using serum-free media.
    Saetre AM; Lillevang ST; Kemp E; Kristensen T
    Transplant Proc; 1996 Apr; 28(2):656-7. PubMed ID: 8623329
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.